Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib individualized schedule in mRCC post PD-1/PD-L1
NCT02579811Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Dec 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in clear cell renal cell carcinoma (ccRCC), sponsored by Case Comprehensive Cancer Center. Started Dec 2015; status: completed.
02
Drugs
axitinib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT02579811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579811.